These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 3345258)

  • 1. Studies on clinical isolates of coagulase-negative staphylococci resistant to methicillin. Evidence of cross-resistance between methicillin and cephalothin.
    Hansen-Nord M; Gahrn-Hansen B; Siboni K
    APMIS; 1988 Feb; 96(2):133-40. PubMed ID: 3345258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cephalosporin susceptibility of methicillin-resistant, coagulase-negative staphylococci.
    Menzies RE; Cornere BM; MacCulloch D
    Antimicrob Agents Chemother; 1987 Jan; 31(1):42-5. PubMed ID: 3646002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibilities of four species of coagulase-negative staphylococci.
    Fass RJ; Helsel VL; Barnishan J; Ayers LW
    Antimicrob Agents Chemother; 1986 Oct; 30(4):545-52. PubMed ID: 3539009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal action of nafcillin, vancomycin, and three cephalosporins against nafcillin-susceptible and nafcillin-resistant coagulase-negative staphylococci.
    Mordenti JJ; Davis RH; Lammel CJ; Brooks GF
    Diagn Microbiol Infect Dis; 1986 May; 5(1):1-8. PubMed ID: 3635453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species dependent variability in the susceptibility of coagulase-negative staphylococci to various antimicrobial agents.
    Rolston KV; Thirolf P; Ho DS; Bodey GP
    J Antimicrob Chemother; 1985 Nov; 16(5):659-62. PubMed ID: 3852834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of cephalosporins against coagulase-negative staphylococci.
    Chin NX; Neu NM; Neu HC
    Diagn Microbiol Infect Dis; 1990; 13(1):67-9. PubMed ID: 2331853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification, clinical distribution, and susceptibility to methicillin and 18 additional antibiotics of clinical Staphylococcus isolates: nationwide investigation in Italy.
    Varaldo PE; Cipriani P; Focá A; Geraci C; Giordano A; Madeddu MA; Orsi A; Pompei R; Prenna M; Repetto A
    J Clin Microbiol; 1984 Jun; 19(6):838-43. PubMed ID: 6565709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of methicillin-resistant coagulase-negative staphylococci isolated from a university environment in Thailand.
    Seng R; Leungtongkam U; Thummeepak R; Chatdumrong W; Sitthisak S
    Int Microbiol; 2017 Jun; 20(2):65-73. PubMed ID: 28617524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of cephalosporins against methicillin-resistant coagulase-negative staphylococci.
    Mouton RP; Lampe AS; van Maanen DB; van der Reijden TJ
    Eur J Clin Microbiol; 1984 Apr; 3(2):144-6. PubMed ID: 6562960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of four beta-lactam antibiotics in surgical wound fluid against staphylococci.
    Sørensen TS
    Acta Pathol Microbiol Immunol Scand B; 1985 Dec; 93(6):379-82. PubMed ID: 3834743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides.
    Del' Alamo L; Cereda RF; Tosin I; Miranda EA; Sader HS
    Diagn Microbiol Infect Dis; 1999 Jul; 34(3):185-91. PubMed ID: 10403098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance in coagulase-negative staphylococci.
    Hamilton-Miller JM; Iliffe A
    J Med Microbiol; 1985 Apr; 19(2):217-26. PubMed ID: 3845121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population analysis in strains of Staphylococcus aureus and Staphylococcus epidermidis. II. Cefuroxime and cefotaxime.
    Hansen BG
    Acta Pathol Microbiol Immunol Scand B; 1983 Dec; 91(6):425-9. PubMed ID: 6324530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the antimicrobial susceptibilities of coagulase-negative staphylococci by E-test.
    Barelli C; Minto EC; Martinez R; Darini AL
    Rev Latinoam Microbiol; 1999; 41(2):67-72. PubMed ID: 10932753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of cephalosporins against methicillin-resistant, coagulase-negative staphylococci.
    Laverdiere M; Peterson P; Verhoef J; Williams DN; Sabath LD
    J Infect Dis; 1978 Mar; 137(3):245-50. PubMed ID: 632623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic Diversity of Methicillin-Resistant Coagulase-Negative Staphylococci Isolated from Inpatients and Outpatients.
    Talebi M; Shafiee M; Sadeghi J; Moghadam NA; Saifi M; Pourshafie MR
    Microb Drug Resist; 2016 Mar; 22(2):147-54. PubMed ID: 26248114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of methicillin-resistant coagulase-negative staphylococci from bovine mastitis.
    Fessler AT; Billerbeck C; Kadlec K; Schwarz S
    J Antimicrob Chemother; 2010 Aug; 65(8):1576-82. PubMed ID: 20525989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates.
    Krediet TG; Jones ME; Gerards LJ; Fleer A
    Pediatrics; 1999 Mar; 103(3):E29. PubMed ID: 10049985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population analysis of susceptibility to methicillin, vancomycin, and three cephalosporines in two methicillin-resistant strains of Staphylococcus epidermidis.
    Hansen BG
    Acta Pathol Microbiol Immunol Scand B; 1983 Aug; 91(4):279-84. PubMed ID: 6556002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance of coagulase-negative staphylococci from a Kuwait hospital.
    Udo EE; Jacob LE; Chugh TD
    Microb Drug Resist; 1995; 1(4):315-20. PubMed ID: 9158802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.